Abstract

BackgroundThe 2018 edition of the National Essential drugs List came into effect in September 2018. Relevant policies require that all primary medical and health institutions should supply national essential drugs, while secondary and tertiary medical and health institutions should supply a certain percentage of essential drugs.MethodsOur research used the standard methods of WHO and HAI, selected 50 basic drugs, combined with the actual situation of Hefei City, selected 30 medical institutions and 30 pharmacies, conducted drug availability and affordability studies.ResultsThe availability of the lowest-price generics (LPGs) of essential drug in Hefei is much higher than that of the Originator brands (OBs); the overall affordability is better, but there is a large gap between the affordability levels of OBs and LPGs. OBs are relatively poorly affordable.ConclusionThe implementation of the national essential drug system in Hefei has achieved certain results, but there is still a gap from the expected target. It is recommended to update and adjust the list of essential drugs in accordance with the demand for clinical medicines, ensure that medical and health institutions at all levels supply essential drugs, popularize knowledge of essential drugs, and moderately adjust the price of OBs to reduce the medication burden.

Highlights

  • The 2018 edition of the National Essential drugs List came into effect in September 2018

  • The results show that the essential drug allocation rate for public medical institutions and retail pharmacies is low in Hefei with the lower drug availability

  • This study found that 50% of essential drugs at public medical institutions and retail pharmacies are quite low, and some medicines are hard to find in the market

Read more

Summary

Introduction

The 2018 edition of the National Essential drugs List came into effect in September 2018. Relevant policies require that all primary medical and health institutions should supply national essential drugs, while secondary and tertiary medical and health institutions should supply a certain percentage of essential drugs. WHO proposes that essential medicines should be necessary for public health, and should be accessible at all times, and be applied to all levels of society in appropriate dosage forms. According to the World Health Report 2000, about one-third of the world’s population still lacks access to essential medicines. Despite some health policies aimed at addressing high levels of medical expenses, the high cost of medical services and medicines is still considered to be the main obstacle to access to health care. Medical institutions at all levels should ensure the accessibility of essential medicines, especially essential medicines for the treatment of common diseases and high incidence [1].

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.